Therapy companies

MolMed is a biotechnology company focused on research, development and clinical validation of novel antitumour therapies.

Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.

Hansa Biopharma (previously known as Hansa Medical) is a biopharmaceutical company developing immunomodulating therapies.

AbClon (앱클론(주)) is a developer, manufacturer, and distributor of antibody drugs.

Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets.

Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies.

Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.

Reneo Pharmaceuticals is a pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases.

Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.

Cryoport is a company that specializes in temperature-controlled supply chain solutions.

Allakos is a biotechnology company that develops therapeutics targeting allergic, inflammatory, and proliferative diseases.

Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.